Status:
UNKNOWN
Detection of Early Lung Cancer by Serum Protein Expression Profiling
Lead Sponsor:
University of British Columbia
Conditions:
Non-small Cell Lung Cancer
Eligibility:
All Genders
45-75 years
Brief Summary
Promising new technology exists to examine small proteins that are shed by cancers into the blood stream. The purpose of this study is to see if there are differences in the proteins and protein level...
Detailed Description
A prospective longitudinal patient-based pilot study is proposed whereby surfaced enhanced laser desorption ionization time-of-flight mass spectroscopy (SELDI-TOF-MS) will be used to discover and vali...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Presence of early stage non-small cell lung cancer
- Elective surgical resection of lung lesion at Vancouver General Hospital (VGH)
- No preoperative chemoradiation therapy
- No previous cancer
- Ability to provide informed consent
Exclusion
Key Trial Info
Start Date :
May 1 2005
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2011
Estimated Enrollment :
220 Patients enrolled
Trial Details
Trial ID
NCT00175578
Start Date
May 1 2005
End Date
December 1 2011
Last Update
November 16 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Vancouver General Hospital BC Cancer Agency
Vancouver, British Columbia, Canada